CCOHTA. No. 27 Jan 2004

Size: px
Start display at page:

Download "CCOHTA. No. 27 Jan 2004"

Transcription

1 No. 27 Jan 2004 Before CCOHTA decides to undertake a health technology assessment, a pre-assessment of the literature is performed. Pre-assessments are based on a limited literature search; they are not extensive, systematic reviews of the literature. They are provided here as a quick guide to important, current assessment information on this topic. Readers are cautioned that the pre-assessments have not been externally peer reviewed. Introduction Venous insufficiency (VI) is a chronic condition of incompetent venous circulation, in which the veins do not adequately return blood from the lower limbs back to the heart. This condition usually results from deep vein thrombosis (DVT) or from damage to or the congenital absence of venous valves. VI induces the development of new thrombi in the veins. It typically affects the lower extremities and commonly results in pain; edema; changes in skin colour; or chronic and recurrent skin ulcers in the affected leg. According to previous studies, about 3% to 11% of adults have skin changes and edema as a result of chronic VI. 1 In the United States, about 400,000 to 500,000 out of five million people who show evidence of chronic VI have or will develop a venous leg ulcer. 2,3 Severe cases are associated with recurrent hospitalization, medical expenses, disability or fatal pulmonary embolism. Thus, prevention of the re-occurrence of VI is as important as treatment for existing disorders. External pneumatic compression (EPC) therapy is used to reduce venous stasis by compressing the superficial veins and forcing blood into the deep veins, which then return it to the heart. EPC differs from previous compression therapy in that it involves the use of air as a compression medium. EPC devices are sleeve- or boot-shaped chambers that fill with air and electrical pumps with gauges that provide intermittent compression to the lower extremities. EPC therapy is also known as intermittent pneumatic compression (IPC) therapy. It is mainly used in preventing DVT, but it also acts as an adjuvant therapy for skin ulcers and limb edema. The earliest comparative studies to evaluate its clinical effectiveness were conducted in the 1970s. Many studies show a favourable outcome in reducing venous stasis, though there are inconsistent results. Modifications have been made to IPC devices to enhance their functions. With the assistance of an attached heart monitor, the circulator boot, a boot-shaped pneumatic compression device, provides external pressure that simulates diastolic blood pressure. Compression is timed to coincide with end diastole and thus, to contribute to maximal venous emptying while prompting venous blood return to the heart. Research Questions 1. What is the evidence regarding the clinical effectiveness of EPC therapy for chronic VI compared with the standard treatment? 2. What is the optimal pressure for EPC therapy? 3. What are the contraindications and side effects of EPC therapy?

2 Assessment Process A search strategy for PubMed ( Nov 2003), The Cochrane Library (2003 Issue 4), web sites, clinical practice guidelines and clinical trials registries, according to the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) health technology assessment (HTA) checklist, was developed (Appendix 1). Experts/researchers consulted No experts were consulted during the pre-assessment. Summary of Findings 1. Primary studies: since 1976, 25 randomized controlled trials (RCTs) have been conducted to assess the clinical efficacy of EPC therapy for patients with VI. The trials done in the past 10 years are listed in Table 1. Table 1: Summary of findings from primary studies Author, year, Patients Intervention Results Conclusion design Ginzburg E, 2003, RCT patients received thromboprophylaxis after trauma IPC device versus low molecular weight heparin (LMWH) 2.7% developed DVT in IPC group, while 0.5% developed DVT in LMWH group; 4 patients in each group had major bleeding episodes Grieveson S, 2003, RCT 5 27 patients with ankle edema of venous origin Kiudelis M, 2002, RCT 6 54 patients undergoing elective laparoscopic fundoplications Flowpac pump versus elevation of lower limbs Leg bandages (LB), IPC or intermittent electric calf muscle stimulation (IECS) No significant differences observed in reduced edema between two groups Blood velocity in femoral vein was 20.1 cm/s in IPC group, 20.3 cm/s in IECS group and 23.9 cm/s in LB group IPC might be used safely and effectively for thromboprophylaxis in trauma patients Lower pressures with shorter inflation and deflation times more efficient than higher pressures and long inflation and deflation times IPC is more effective than IECS in reducing venous stasis

3 Maxwell GL, 2001, RCT postoperative gynecologic oncology patients Blanchard J, 1999, RCT patients underwent total knee Tamir L, 1999, RCT 9 Wautrecht, 1996, RCT 10 Westrich GH, 1996, RCT 48 patients after total knee 23 patients underwent brain tumour surgery 122 patients after total knee LMWH versus EPC LMWH versus IPC of foot EPC plus LMWH versus LMWH alone Graded compression stockings (GCS) versus GCS plus IPC Aspirin versus Aspirin plus pneumatic plantarcompression device 2 patients in LMWH group and 1 patient in EPC group diagnosed with DVT; frequency of bleeding complications similar between two groups 26.7% of patients in LMWH group and 64.6% of patients in IPC group developed DVT; 1 patient in LMWH group had severe bleeding Lower limb swelling and pain significantly reduced for EPC group in relation to LMWH group 40% of patients in GCS group and 0% in GCS plus IPC group developed DVT 59% of patients in Aspirin group and 27% of patients in EPC group developed DVT; patients with compression device had less edema than those who used Aspirin alone LMWH and EPC are similarly effective in postoperative prophylaxis of thromboembolism; both modalities are reasonable choices for prophylaxis in this patient population LMWH is superior to IPC of foot for thromboprophylaxis after total knee EPC therapy is important prophylactic addition to antithrombotic treatment in overcoming hazardous clinical implications of venous stasis GCS combined with IPC more effective than GCS alone in preventing postoperative DVT in this patient population Study confirmed safety and efficacy of EPC plus Aspirin compared with Aspirin alone and supports use of mechanical compression for prophylaxis against DVT and for reduction of edema in study population

4 Goldhaber SZ, 1995, RCT patients after coronary artery bypass surgery Lieberman JR, 231 patients 1994, RCT 12 after total hip arthroplasties with use of hypotensive epidural anesthesia McCulloch JM, 1994, RCT patients with chronic venous ulcers Bradley JG, 1993, RCT patients after total hip GCS plus IPC versus GCS EPC plus Aspirin versus Aspirin IPC plus Unna s boot plus local wound care versus Unna s boot plus local wound care IPC plus standard therapy versus standard therapy DVT was diagnosed in 19% of patients in IPC plus GCS group and in 22% of patients in GCS group, but difference was not significant 6% of patients in EPC plus Aspirin group had DVT, while 8% of patients in Aspirin group had DVT; difference was not significant Healing rate: 0.15 cm 2 /day in IPC group, compared with 0.08 cm 2 /day in control group; difference was significant Incidence of DVT was 6.6% in pumped group and 27.27% in nonpumped group; result was significant Addition of IPC did not add significant incremental benefit to GCS alone for DVT prophylaxis in study population Combination of hypotensive epidural anesthesia and Aspirin is effective prophylaxis against DVT in study population IPC is beneficial in management of VI ulcers Chemical prophylaxis plus IPC reduce incidence of thromboembolic complications further than chemical prophylaxis alone

5 2. Systematic reviews and meta-analysis: five systematic reviews regarding the efficacy of EPC therapy were identified. Table 2: Summary of findings from systematic reviews Author, year Study design Results Authors conclusions (country) Berliner E, 2003 (US) 15 Systematic review on 91 articles, 7 of which contained relevant clinical trials; medical interventions were pneumatic compression therapy versus compression stockings, bandages, or Unna s boot; included articles were searched before March 8, 2001 Results from follow-up studies indicated improvements of signs and symptoms of venous edema; results from RCTs showed that symptoms improved in treatment group compared to control group, but in some trials, difference was not significant Several studies showed significant improvement with use of pneumatic compression devices on chronic leg ulcers that had not healed after use of other methods; long-term use of pneumatic compression devices at home may be alternative to other compression therapies on chronic VI and leg ulcers Mani R, 2003 (UK) 16 Cochrane review on effect of IPC on venous leg ulcer healing and quality of life, included RCTs searched until end of January 2001 One trial found increased ulcer healing with IPC plus compression than with compression alone; two trials found no evidence of benefit for IPC plus compression compared with compression alone; Further trials required to determine whether IPC increases healing of venous leg ulcers Freedman KB, Meta-analysis of 2000 (US) 17 efficacy and safety of agents used for thromboembolic prophylaxis in patients undergoing total hip ; 52 RCTs from January 1996 to May 1998 included one trial found no difference between IPC and compression bandages alone Risk of DVT was 20.7% for EPC, while it was 48.5% for placebo; compared with placebo (1.51%), EPC was associated with significantly lower risk of pulmonary embolism (0.26%) Best prophylactic agent in terms of efficacy and safety was warfarin, followed by pneumatic compression

6 Westrich GH, Meta-analysis to 2000 (US) 18 assess efficacy of 4 regimes for thromboembolic prophylaxis after total knee ; 23 RCTs done between January 1980 and December 1997 included Palfreyman SJ, 1998 (UK) 19 Systematic review on compression therapy of venous leg ulcers; among 8 trials identified, 2 RCTs compared pneumatic compression with compression stockings or Unna s boot Incidence of DVT (17%) and asymptomatic pulmonary embolism (6.3%) were lower in EPC group than in other groups More patients healed in treatment arm of study with pneumatic compression, pool odds ratios for total number of ulcers healed : 8.45, 95% CI (0.627, ). EPC had lowest incidence of thromboembolism and is acceptable for prophylaxis in total knee No benefit found for IPC therapy when results from trials were pooled; probably due to small sample size of 2 RCTs, and heterogeneity between them EPC reduces the risk of DVT for patients who cannot walk due to trauma, joint surgery or neurosurgery. There is still limited evidence, however, supporting the effect of EPC on the healing of venous ulcers and other disorders resulting from chronic VI. Conclusion There is a large potential patient population who could use this treatment. Although several systematic reviews were identified in the preliminary literature search, the most recent RCTs found in these reviews were done in Since then, more RCTs and other studies have been performed to evaluate the safety and efficacy of EPC devices. An evidencebased assessment would be timely. References 1. Nicolaides AN. Investigation of chronic venous insufficiency: a consensus statement. Circulation 2000;102(20):E Available: (accessed 2003 Nov 26). 2. Dalen JE, Paraskos JA, Ockene IS, Alpert JS, Hirsh J. Venous thromboembolism. Scope of the problem. Chest 1986;89(5 Suppl):370S-3S. 3. Coon WW, Willis PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 1973;48(4): Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg 2003;90(11): Grieveson S. Intermittent pneumatic compression pump settings for the optimum reduction of oedema. J Tissue Viability 2003;13(3):98-100, 102, 104.

7 6. Kiudelis M, Endzinas Z, Mickevicius A, Pundzius J. Venous stasis and deep vein thrombosis prophylaxis during laparoscopic fundoplication [in German]. Zentralbl Chir 2002;127(11): Maxwell GL, Synan I, Dodge R, Carroll B, Clarke-Pearson DL. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 2001;98(6): Blanchard J, Meuwly JY, Leyvraz PF, Miron MJ, Bounameaux H, Hoffmeyer P, et al. Prevention of deepvein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br 1999;81(4): Tamir L, Hendel D, Neyman C, Eshkenazi AU, Ben Zvi Y, Zomer R. Sequential foot compression reduces lower limb swelling and pain after total knee. J Arthroplasty 1999;14(3): Wautrecht JC, Macquaire V, Vandesteene A, Daoud N, Golzarian J, Capel P, et al. Prevention of deep vein thrombosis in neurosurgical patients with brain tumors: a controlled, randomized study comparing graded compression stockings alone and with intermittent sequential compression. Correlation with preand postoperative fibrinolysis. Preliminary results. Int Angiol 1996;15(3 Suppl 1): Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA, Cohn LH. Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies). Am J Cardiol 1995;76(14): Lieberman JR, Huo MM, Hanway J, Salvati EA, Sculco TP, Sharrock NE. The prevalence of deep venous thrombosis after total hip with hypotensive epidural anesthesia. J Bone Joint Surg Am 1994;76(3): McCulloch JM, Marler KC, Neal MB, Phifer TJ. Intermittent pneumatic compression improves venous ulcer healing. Adv Wound Care 1994;7(4):22-4, Bradley JG, Krugener GH, Jager HJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip. J Arthroplasty 1993;8(1): Berliner E, Ozbilgin B, Zarin DA. A systematic review of pneumatic compression for treatment of chronic venous insufficiency and venous ulcers. J Vasc Surg 2003;37(3): Mani R, Vowden K, Nelson EA. Intermittent pneumatic compression for treating venous leg ulcers [Cochrane Review]. In: The Cochrane Library, Issue 4. Oxford: Update Software; Freedman KB, Brookenthal KR, Fitzgerald RH, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip. J Bone Joint Surg Am 2000;82- A(7): Westrich GH, Haas SB, Mosca P, Peterson M. Meta-analysis of thromboembolic prophylaxis after total knee. J Bone Joint Surg Br 2000;82(6): Palfreyman SJ, Lochiel R, Michaels JA. A systematic review of compression therapy for venous leg ulcers. Vasc Med 1998;3(4):

8 Pre-assessment Search Appendix 1 Databases Limits Hits Keywords MEDLINE (Pubmed) to 11 Nov 2003 Human circulator boot*[all fields] OR enddiastolic pneumatic compression boot*[all fields] OR Pneumatic Boot*[all fields] OR Pneumatic compression[all fields] AND 2. Venous [MeSH] OR venous insufficienc*[title/abstract] OR Venous Thrombosis[MeSH] OR deep venous thrombosis[title/abstract] OR DVT[title/abstract] OR Varicose Veins[MeSH] OR varicose vein[title/abstract] OR varicose veins[title/abstract] OR Dermatitis[MeSH] OR Stasis dermatitis[title/abstract] OR Leg Ulcer[MeSH] OR leg ulcer[title/abstract] OR leg ulcers[title/abstract] OR foot ulcer[title/abstract] OR foot ulcers[title/abstract] OR venous ulcer[title/abstract] OR venous Cochrane Library 2003 Issue 4 ulcers[title/abstract] ((circulator next boot*) or (end-diastolic next pneumatic next compression next boot*) or (pneumatic next boot*) or (pneumatic next compression)) AND 2. ((venous next insufficienc*) or (deep next venous next thrombosis) or dvt or (varicose next vein) or (varicose next veins) or (stasis next dermatitis) or (leg next ulcer) or (leg next ulcers) or (foot next ulcer) or (foot next ulcers) or (venous next ulcer) or (venous next ulcers)) OR VENOUS INSUFFICIENCY explode tree 1 (MeSH) OR VENOUS THROMBOSIS explode tree 1 (MeSH) OR VARICOSE VEINS explode tree 1 (MeSH) OR DERMATITIS explode tree 1 (MeSH) OR LEG ULCER explode tree 1 (MeSH)

9 Search of HTA, near- HTA websites for published, in-progress, planned reports. Search of trial registers. As per CCOHTA HTA Checklist

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H

Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein

More information

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients? July 2015 Rapid Review Evidence Summary McGill University Health Centre: Division of Nursing Research and MUHC Libraries What evidence exists that describes the efficacy of mechanical prophylaxis for venous

More information

Anticoagulation for prevention of venous thromboembolism

Anticoagulation for prevention of venous thromboembolism Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,

More information

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk? Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP

More information

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Clinical Position Statement Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Effective: October 2017 Next Review: September 2018 CLINICAL POSITION STATEMENT Postsurgical

More information

Protocol. Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Protocol. Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Postsurgical Outpatient Use of Limb Compression Devices for (10128) (Formerly Outpatient Use of Limb Pneumatic Compression Devices for ) Medical Benefit Effective Date: 07/01/14 Next Review Date: 03/15

More information

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability

More information

Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient

Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient Cheung Shuk Shan, Susana (APN,O&T, PYNEH) 15 May, 2013 Total Knee Replacement (TKR) TKR is a common

More information

Misunderstandings of Venous thromboembolism prophylaxis

Misunderstandings of Venous thromboembolism prophylaxis Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario

More information

PNEUMATIC COMPRESSION DEVICES IN THE HOME SETTING

PNEUMATIC COMPRESSION DEVICES IN THE HOME SETTING Status Active Medical and Behavioral Health Policy Section: Medicine Policy Number: II-60 Effective Date: 05/19/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should

More information

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations General Guideline Title Prevention of deep vein thrombosis and pulmonary embolism. Bibliographic Source(s) American College of Obstetricians and Gynecologists (ACOG). Prevention of deep vein thrombosis

More information

Page: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Page: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Last Review Status/Date: March 2014 Page: 1 of 13 Compression Devices for Venous Description Patients undergoing major orthopedic surgery are at increased risk for venous thromboembolism (VTE). Patients

More information

VTE Prophylaxis. NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients

VTE Prophylaxis. NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients NICE guidance NICE guidance (MTG19) supports the use of the geko device for people who have a high risk of VTE and for whom pharmacological or other mechanical methods of VTE prevention are impractical

More information

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness

More information

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical

More information

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Slide 1. Slide 2. Slide 3. Outline of This Presentation Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous

More information

End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema. Original Policy Date

End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema. Original Policy Date MP 2.02.12 End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date

More information

VTE Prophylaxis. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients

VTE Prophylaxis. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients VTE Prophylaxis Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients ge NIC NI ko T E gu CE M de id gu vi an ce ce id fo (M rr T an ed G1 ce uc 9) in s u g th p p o e ris

More information

VTE Prophylaxis. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients

VTE Prophylaxis. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients VTE Prophylaxis Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients ge NIC NI ko T E gu CE M de id gu vi an ce ce id fo (M rr T an ed G1 ce uc 9) in s u g th p p o e ris

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction Venous Thromboembolism Prophylaxis following Lower Extremity Orthopedic Surgery: A Review of the Biomedical Research Literature and Evidence-Based Policy in the United States. Adam Goldfarb, M.A., D.C.,

More information

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism(review)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism(review) Cochrane Database of Systematic Reviews Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism Kakkos SK, Caprini JA, Geroulakos G, Nicolaides

More information

Management of Post-Thrombotic Syndrome

Management of Post-Thrombotic Syndrome Management of Post-Thrombotic Syndrome Thanainit Chotanaphuti Phramongkutklao College of Medicine Bangkok, Thailand President of CAOS Asia President of Thai Hip & Knee Society President of ASEAN Arthroplasty

More information

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital VTE is common and dangerous 5 VTE is Common VTE Incidence: 1.5 / 1000 per year

More information

VTE Prophylaxis. Serving an unmet need in high-risk acute stroke patients.

VTE Prophylaxis. Serving an unmet need in high-risk acute stroke patients. VTE Prophylaxis Serving an unmet need in high-risk acute stroke patients www.gekodevices.com Providing venous thromboembolism (VTE) prophylaxis to at-risk stroke patients The risk of venous thromboembolism

More information

Page: 1 of 14. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Page: 1 of 14. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Subject: Post-Surgical Outpatient Use of Limb Page: 1 of 14 Last Review Status/Date: March 2015 Post-Surgical Outpatient Use of Limb Compression Devices for Venous Description Patients undergoing major

More information

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms DATE: 23 August 2011 CONTEXT AND POLICY ISSUES: Thromboembolism occurs when a blood

More information

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders SURGICAL GRAND ROUNDS March 17 th, 2007 Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders Guillermo Escobar, M.D. LMWH vs UFH Jayer s sales pitch: FALSE LMW is

More information

Prevention of Venous Thromboembolism

Prevention of Venous Thromboembolism Prevention of Venous Thromboembolism Surgical Care Improvement Project Dale W. Bratzler, DO, MPH President and CEO Dale W. Bratzler, DO, MPH Oklahoma Foundation for Medical Quality QIOSC Medical Director

More information

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Policy Number: 1.01.28 Last Review: 4/2018 Origination: 4/2013 Next Review: 4/2019 Policy Blue Cross and Blue

More information

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Postsurgical Home Use of Limb Compression Devices for Venous File Name: Origination: Last CAP Review: Next CAP Review: Last Review: postsurgical_home_use_of_limb_ compression_devices_for_vte_prophylaxis

More information

Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary,

More information

VASCULAR WOUNDS PATHOPHYSIOLOGY AND MANAGEMENT

VASCULAR WOUNDS PATHOPHYSIOLOGY AND MANAGEMENT VASCULAR WOUNDS PATHOPHYSIOLOGY AND MANAGEMENT Lucy Stopher, A/CNS Vascular Surgery ...it is best to think of a wound not as a disease, but rather as a manifestation of disease. Joe McCulloch In order

More information

Guideline Quick View: Venous Thromboembolism

Guideline Quick View: Venous Thromboembolism Guideline Quick View: Venous Thromboembolism The AORN Guideline Quick View is a key component of Guideline Essentials, a suite of online implementation tools designed to help the perioperative team translate

More information

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14, 09/15/15,09/21/17. THROMBOEMBOLISM PROPHYLAXIS

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14, 09/15/15,09/21/17. THROMBOEMBOLISM PROPHYLAXIS MEDICAL POLICY REVISED DATE: 06/26/14, 09/15/15,09/21/17. PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,

More information

Venous Thromboembolism. Prevention

Venous Thromboembolism. Prevention Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and

More information

1. SCOPE of GUIDELINE:

1. SCOPE of GUIDELINE: Page 1 of 35 CLINICAL PRACTICE GUIDELINE: Venous Thromboembolism (VTE) Prevention Guideline: Thromboprophylaxis AUTHORIZATION: VP, Medicine Date Approved: May 17, 2012 Date Revised: Vancouver Coastal Health

More information

VTE Prophylaxis. NEW NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients

VTE Prophylaxis. NEW NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients NEW NICE guidance NICE guidance (MTG19) supports the use of the geko device for people who have a high risk of VTE and for whom pharmacological or other mechanical methods of VTE prevention are impractical

More information

MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION REVISED DATE: 06/26/14, 10/15/15, 06/16/16, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria

More information

Venous Thromboembolism Prophylaxis: Checked!

Venous Thromboembolism Prophylaxis: Checked! Venous Thromboembolism Prophylaxis: Checked! William Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention, Safer

More information

Walk Away From Risk. Mimic ambulation to prevent DVT

Walk Away From Risk. Mimic ambulation to prevent DVT » Walk Away From Risk Mimic ambulation to prevent DVT Walk Away From Risk VenaFlow Elite s unique technology is proven to mimic ambulation and reduce DVT to help healthcare facilities and patients walk

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Postsurgical Home Use of Limb Compression Devices Page 1 of 20 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See Also: Postsurgical Home Use of Limb Compression

More information

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital

More information

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Policy Number: 1.01.28 Last Review: 4/2019 Origination: 4/2013 Next Review: 4/2020 Policy Blue Cross and Blue

More information

Pre-operative oedema reduction

Pre-operative oedema reduction Pre-operative oedema reduction Accelerating readiness for theatre in ankle fracture patients requiring Open Reduction Internal Fixation (ORIF). www.gekodevices.com Accelerating readiness to theatre A new

More information

Challenges in Anticoagulation and Thromboembolism

Challenges in Anticoagulation and Thromboembolism Challenges in Anticoagulation and Thromboembolism Ethan Cumbler M.D. Assistant Professor of Medicine Hospitalist Medicine Section University of Colorado Denver May 2010 No Conflicts of Interest Objectives

More information

VeinOPlus Vascular Peripheral Vascular & Wound Therapy Device

VeinOPlus Vascular Peripheral Vascular & Wound Therapy Device VeinOPlus Vascular Peripheral Vascular & Wound Therapy Device Calf Muscle Pump Dysfunction Therapy Increases blood flow, accelerates wound healing, and improves CVD and PAD symptoms Tomorrow s Technology

More information

Deep venous thrombosis and pulmonary embolism in joint replacement surgery

Deep venous thrombosis and pulmonary embolism in joint replacement surgery Deep venous thrombosis and pulmonary embolism in joint replacement surgery Even though joint replacement surgery is an effective procedure and in expert hands yields a low complication rate, deep venous

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE VENOUS THROMBOEMBOLISM PROPHYLAXIS SCOPE Provincial Acute and Sub-Acute Care Facilities APPROVAL AUTHORITY Alberta Health Services Executive Committee SPONSOR Vice President, Quality and Chief Medical

More information

Post-Thrombotic Syndrome(PTS) Conservative Treatment Options

Post-Thrombotic Syndrome(PTS) Conservative Treatment Options Post-Thrombotic Syndrome(PTS) Conservative Treatment Options Dr. S. Kundu Scarborough Hospital-General Division Scarborough Vascular Group Toronto Endovascular Centre The Vein Institute of Toronto Scarborough

More information

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis Reducing Harm Improving Healthcare Protecting Canadians VENOUS THROMBOEMBOLISM PREVENTION Getting Started Kit Section 2: Evidence-Based Appropriate VTE Prophylaxis January 2017 www.patientsafetyinstitute.ca

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

Dr Paul Thibault. Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology

Dr Paul Thibault. Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology Dr Paul Thibault Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology Prescribing Effective Compression and PTS Dr Paul Thibault Phlebologist, Newcastle,

More information

VTE in the Trauma Population

VTE in the Trauma Population VTE in the Trauma Population Erik Peltz, D.O. February 11 th, 2015 * contributions from Eduardo Gonzalez, M.D. University of Colorado T-32 Research Fellow The problem. VTE - Scope of the Problem One of

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 49 Effective Health Care Program Venous Thromboembolism Prophylaxis in Orthopedic Surgery Executive Summary Background ajor orthopedic surgery describes three surgical

More information

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS The West London Medical Journal 2010 Vol 2 No 4 pp 19-24 AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS Soneji ND Agni NR Acharya MN Anjari

More information

Anesthesia for Total Hip and Knee Arthroplasty

Anesthesia for Total Hip and Knee Arthroplasty Anesthesia for Total Hip and Knee Arthroplasty Typical approach Describe anesthesia technique Rather Describe issues with THA and TKA How anesthesia can modify Issues Total Hip Total Knee Blood Loss ++

More information

Pre-operative oedema reduction

Pre-operative oedema reduction Pre-operative oedema reduction Accelerating readiness for theatre in ankle fracture patients requiring Open Reduction Internal Fixation (ORIF). www.gekodevices.com Managing pre-operative oedema Accelerating

More information

Deep vein thrombosis leads to catastrophic RECONSTRUCTIVE

Deep vein thrombosis leads to catastrophic RECONSTRUCTIVE RECONSTRUCTIVE Deep Venous Thrombosis Practice and Treatment Strategies among Plastic Surgeons: Survey Results George Broughton, II, M.D., Ph.D. Jose L. Rios, M.D. Rod J. Rohrich, M.D. Spencer A. Brown,

More information

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 7 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including

More information

Onpulse TM technology and the geko TM device: The development of a novel system for the prevention of venous thromboembolism

Onpulse TM technology and the geko TM device: The development of a novel system for the prevention of venous thromboembolism Onpulse TM technology and the geko TM device: The development of a novel system for the prevention of venous thromboembolism Tucker AT, Bain DS Jawad H, Bain DS, Dawson H, Adams K, Elnahhas T, Johnston

More information

TRANSPARENCY COMMITTEE OPINION. 18 April 2007

TRANSPARENCY COMMITTEE OPINION. 18 April 2007 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 April 2007 ARIXTRA 2.5 mg/0.5 ml, solution for injection in prefilled syringe Pack of 2 (CIP: 359 225-4) Pack of

More information

RCT on GCS/LMWH vs LMWH in VTE prophylaxis

RCT on GCS/LMWH vs LMWH in VTE prophylaxis RCT on GCS/LMWH vs LMWH in VTE prophylaxis GAPS: Graduated compression as an Adjunct to Pharmacoprophylaxis in Surgery A Multi-Centre Randomised Clinical Trial Joseph Shalhoub, Alun H Davies on behalf

More information

Best Practice for Deep Vein Thrombosis Prevention: A Research Review. Pamela Dusseau Carly Macklin Natalie Russell Danielle Williams

Best Practice for Deep Vein Thrombosis Prevention: A Research Review. Pamela Dusseau Carly Macklin Natalie Russell Danielle Williams Running Head: BEST PRACTICE FOR DEEP VEIN THOMBOSIS PREVENTION 1 Best Practice for Deep Vein Thrombosis Prevention: A Research Review Pamela Dusseau Carly Macklin Natalie Russell Danielle Williams Ferris

More information

Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons

Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons Original Article Knee Surg Relat Res 2016;28(3):207-212 http://dx.doi.org/10.5792/ksrr.2016.28.3.207 pissn 2234-0726 eissn 2234-2451 Knee Surgery & Related Research Prophylaxis for Venous Thromboembolism

More information

End-Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema

End-Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema End-Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary,

More information

pressure of compression stockings matters (clinical importance of pressure)

pressure of compression stockings matters (clinical importance of pressure) Classification of Compression Stockings ICC Meeting, Copenhagen, May 17, 2013. pressure of compression stockings matters (clinical importance of pressure) Giovanni Mosti; Lucca, Italy disclosure no conflict

More information

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS PROPHYLAXIS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent

More information

Are There Clinical Meaning on Asymptomatic Pulmonary Embolism After Total Knee Arthroplasty?

Are There Clinical Meaning on Asymptomatic Pulmonary Embolism After Total Knee Arthroplasty? Are There Clinical Meaning on Asymptomatic Pulmonary Embolism After Total Knee Arthroplasty? * 1,2 ATSUSHI SATO, MD, PhD, * 1,2 Takayuki Koya, * 2,3 Hiroshi Takagi, * 2 Jun Oike,, * 2 Saki Yagura, * 2

More information

Key words: cardiac rehabilitation; coronary bypass; deep vein thrombosis; prevention; prophylaxis

Key words: cardiac rehabilitation; coronary bypass; deep vein thrombosis; prevention; prophylaxis Deep Vein Thrombosis Among Patients Entering Cardiac Rehabilitation After Coronary Artery Bypass Surgery* Marco Ambrosetti, MD; Mario Salerno, MD; Mara Zambelli, MD; Filippo Mastropasqua, MD; Roberto Tramarin,

More information

Clinical Practice Guideline for Patients Requiring Total Hip Replacement

Clinical Practice Guideline for Patients Requiring Total Hip Replacement Clinical Practice Guideline for Patients Requiring Total Hip Replacement Inclusions Patients undergoing elective total hip replacement Exclusions Patients with active local or systemic infection or medical

More information

The Evidence Base for Treating Acute DVT

The Evidence Base for Treating Acute DVT The Evidence Base for Treating Acute DVT Mr Chung Sim Lim Consultant Vascular Surgeon and Honorary Lecturer Royal Free London NHS Foundation Trust and University College London NIHR UCLH Biomedical Research

More information

Medical Policy Original Effective Date: 01/23/2019

Medical Policy Original Effective Date: 01/23/2019 Page 1 of 12 Disclaimer Refer to the member s specific benefit plan and Schedule of Benefits to determine coverage. This may not be a benefit on all plans or the plan may have broader or more limited benefits

More information

Technology appraisal guidance Published: 25 January 2012 nice.org.uk/guidance/ta245

Technology appraisal guidance Published: 25 January 2012 nice.org.uk/guidance/ta245 Apixaban for the prevention ention of venous thromboembolism after total hip or knee replacement in adults Technology appraisal guidance Published: 25 January 2012 nice.org.uk/guidance/ta245 NICE 2018.

More information

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY OBJECTIVE: To outline a practical approach for the prevention of venous thromboembolism (VTE) in patients undergoing non-orthopedic surgery. BACKGROUND: VTE is

More information

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE Results from

More information

Challenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest

Challenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest Challenges in Anticoagulation Bridging and Emerging Therapies Ethan Cumbler MD FACP Associate Professor of Medicine Hospitalist Medicine Section University of Colorado Denver 2011 Disclosures and Relationships

More information

The optimal regime of antithrombotic prophylaxis

The optimal regime of antithrombotic prophylaxis Prevention of deep-vein thrombosis after total knee replacement RANDOMISED COMPARISON BETWEEN A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN) AND MECHANICAL PROPHYLAXIS WITH A FOOT-PUMP SYSTEM J. Blanchard,

More information

1/27/2016. Disclosure. Goals. The Risk and Prevention of Venous Thromboembolism (VTE) in Patients With Foot and Ankle Pathology

1/27/2016. Disclosure. Goals. The Risk and Prevention of Venous Thromboembolism (VTE) in Patients With Foot and Ankle Pathology The Risk and Prevention of Venous Thromboembolism (VTE) in Patients With Foot and Ankle Pathology STEVEN STEINLAUF, MD THE ORTHOPAEDIC FOOT AND ANKLE INSTITUTE OF SOUTH FLORIDA CLINICAL ASSISTANT PROFESSOR

More information

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) after hip or knee replacement surgery Always read the

More information

NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89

NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89 Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89 NICE 2018. All rights

More information

Deep venous thrombosis (DVT) occurs frequently

Deep venous thrombosis (DVT) occurs frequently Ann Vasc Dis Vol.5, No.3; 2012; pp 328 333 2012 Annals of Vascular Diseases doi: 10.3400/avd.oa.12.00049 Original Article Deep Vein Thrombosis in Orthopedic Surgery of the Lower Extremities Masatoshi Motohashi,

More information

Venous thromboembolism: reducing the risk

Venous thromboembolism: reducing the risk Issue date: January 2010 Venous thromboembolism: reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital This guideline

More information

CANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital

CANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital CANCER ASSOCIATED THROMBOSIS Pankaj Handa Department of General Medicine Tan Tock Seng Hospital My Talk Today 1.Introduction 2. Are All Cancer Patients at Risk of VTE? 3. Should All VTE Patients Be Screened

More information

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer

More information

ASH Draft Recommendations for VTE Prevention in Surgical Hospitalized Patients DRAFT

ASH Draft Recommendations for VTE Prevention in Surgical Hospitalized Patients DRAFT ASH Draft Recommendations for VTE Prevention in Surgical Hospitalized Patients INTRODUCTION American Society of Hematology (ASH) guidelines are based on a systematic review of available evidence. Through

More information

Pre-operative oedema reduction

Pre-operative oedema reduction Pre-operative oedema reduction Accelerating readiness for theatre in ankle fracture patients requiring Open Reduction Internal Fixation (ORIF). www.gekodevices.com A new approach using OnPulse TM technology

More information

Thromboembolic events (TEs), such as deep vein

Thromboembolic events (TEs), such as deep vein An Original Study Use of Low-Molecular-Weight Heparin and a Deep Vein Thrombosis Protocol to Prevent DVT in Elderly Patients With Trauma Douglas J.E. Schuerer, MD, and Joseph Borrelli, Jr., MD Abstract

More information

10/8/2012. Disclosures. Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines. Goals and Objectives. Outline

10/8/2012. Disclosures. Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines. Goals and Objectives. Outline Disclosures Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines No relevant conflicts of interest related to the topic presented. Cyndy Brocklebank, PharmD, CDE Chronic Disease Management

More information

Listing Form: Heart or Cardiovascular Impairments. Medical Provider:

Listing Form: Heart or Cardiovascular Impairments. Medical Provider: Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition

More information

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy

More information

Incidence of DVT Post- Hip or Knee Replacement. A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence

Incidence of DVT Post- Hip or Knee Replacement. A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence Incidence of DVT Post- Hip or Knee Replacement A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence Background DVTs Pulmonary Embolisms Death Symptomatic DVTs (leg

More information

Incidence of Venous Thromboembolism After Arthroscopic Anterior Cruciate Ligament Reconstruction

Incidence of Venous Thromboembolism After Arthroscopic Anterior Cruciate Ligament Reconstruction Incidence of Venous Thromboembolism After Arthroscopic Anterior Cruciate Ligament Reconstruction Masaki Nagashima 1,2 Toshiro Otani 3 Hiroyuki Seki 1,2 Kenichiro Takeshima 2 Nobuto Origuchi 4 Ken Ishii

More information

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT) Page 1 of 11 Venous Thromboembolism () What is a clot or Venous Thromboembolism ()? Blood clots are called Venous Thromboembolism (). There are 2 main types: is a clot in a deep vein, usually an arm or

More information

Taken into account multidiscilinary aspect of Vascular Compression

Taken into account multidiscilinary aspect of Vascular Compression The Vascular Center : A model to improve patient care Taken into account multidiscilinary aspect of Vascular Compression F. Vin C. Gardon-Mollard Compression Therapy is an efficient treatment for the management

More information

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information